Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Dow
AstraZeneca
Baxter
Mallinckrodt
Moodys
Harvard Business School

Last Updated: December 8, 2019

DrugPatentWatch Database Preview

Litigation Details for VISTA HEALTHPLAN, INC. v. CEPHALON, INC. (E.D. Pa. 2006)

See Plans and Pricing

« Back to Dashboard

VISTA HEALTHPLAN, INC. v. CEPHALON, INC. (E.D. Pa. 2006)

Docket   Start Trial Date Filed 2006-05-01
Court District Court, E.D. Pennsylvania Date Terminated 2015-12-17
Cause 15:1 Antitrust Litigation Assigned To Mitchell S. Goldberg
Jury Demand Defendant Referred To David R. Strawbridge
Parties AVMED, INC.; BARR LABORATORIES, INC.; CEPHALON, INC.; DEBRA LANGAN; DISTRICT COUNCIL 37 HEALTH & SECURITY PLAN; ECKERD CORPORATION; JEFFREY R. KRINSK; MYLAN LABORATORIES, INC.; MYLAN PHARMACEUTICALS, INC.; PENNSYLVANIA EMPLOYEES BENEFIT TRUST FUND; PENNSYLVANIA TURNPIKE COMMISSION; RANBAXY LABORATORIES, LTD.; RANBAXY PHARMACEUTICALS, INC.; SHIRLEY PANEBIANO; TEVA PHARMACEUTICAL INDUSTRIES, LTD.; TEVA PHARMACEUTICALS USA, INC.; VISTA HEALTHPLAN, INC.
Patents 5,618,845
Attorneys ANTHONY S. VOLPE; BETHANY MARVIN STEVENS; C. FAIRLEY SPILLMAN; CATHERINE E. CREELY; DANIEL P. MARGOLSKEE; DANIELLE R. FOLEY; DAVID E. EDWARDS; DAVID G. ADAMS; DAVID J. CREAGAN; DAVID L. COMERFORD; DAVID R. MARRIOTT; DAVID S. NALVEN; EDWARD F. MANNINO; ELIZABETH M. RYAN; EMILY R. WHELAN; EVAN R. CHESLER; GREGORY L. SKIDMORE; GREGORY P. TERAN; J. DOUGLAS BALDRIDGE; JAMES C. BURLING; JAY P. LEFKOWITZ; JEFFERY A. DAILEY; JEFFREY B. KORN; JEFFREY C. SWANN; JEFFREY L. KODROFF; JOHN A. MACORETTA; JOHN C. O'QUINN; JOHN J. O'MALLEY; JOSEPH E. WOLFSON; JOSEPH H. MELTZER; KAREN N. WALKER; KATHERINE M. KATCHEN; KENDALL SCOTT ZYLSTRA; KEVIN B. LOVE; LATHROP B. NELSON , III; LAURENCE SCHOEN; LAWRENCE KENDALL SATTERFIELD; LINDSAY J. TIMLIN; LISA JOSE FALES; MARK A. FORD; MARK M. SANDMANN; MARY ANN GEPPERT; MARY J. EDWARDS; MARY KAY COSTELLO; MATTHEW RYAN VARZALLY; MICHAEL G. MCLELLAN; MICHAEL MCLELLAN; MICHAEL N. ONUFRAK; MICHELLE D. MILLER; MOLLY GEISSENHAINER; MOLLY T. CUSSON; MONICA L. REBUCK; PAUL B. HEWITT; PAUL T. MCGURKIN , JR.; PETER A. SPAETH; PETER J. KOLOVOS; REGINALD D. STEER; RICHARD D. SCHWARTZ; ROBERT C. GRIFFITH; ROBERT J. GUNTHER , JR.; ROBERT W. SINK; ROWAN D. WILSON; SARAH CHOI; STEVE D. SHADOWEN; TERENCE S. ZIEGLER; THEODORE M. LIEVERMAN; VINCENT E. VERROCCHIO; WILLIAM H. ROONEY; WILLIAM RICHARD RESTIS; YIN ZHOU
Firms Akin Gump Strauss Hauer & Feld LLP; Akin Gump Strauss Hauer and Feld; Berger & Montague, P.C.; Cravath Swaine and Moore; Cravath, Swaine & Moore LLP; Faruqi and Faruqi LLP; Finkelstein & Krinsk; Finkelstein Thompson LLP; Hagens Berman Sobol Shapiro LLP; Hangley Aronchich Segal Pudlin & Schiller; Hanzman Criden & Love, P.A.; Hilliard & Shadowen LLC; Kessler Topaz Meltzer & Check LLP; Kirkland & Ellis LLP; Kirkland and Ellis LLP; Law Offices of Robert W. Sink; Montgomery McCracken Walker and Rhoads, L.L.P.; Rawlings & Assoc Pllc; Rawlings & Associates Pllc; Spector, Roseman Kodroff & Willis, P.C.; United States Attorney's Office; Venable LLP; White & Williams LLP; White and Williams LLP; Willkie Farr & Gallagher LLP; Willkie Farr & Gallagher, LLP; Wilmer Butler Pickering Hale and Dorr LLP; Wilmer Cutler Pickering Hale and Dorr LLP; Wilmer, Cutler, Pickering, Hale & Dorr, LLP; WilmerHale
Link to Docket External link to docket
Small Molecule Drugs cited in VISTA HEALTHPLAN, INC. v. CEPHALON, INC.
The small molecule drug covered by the patent cited in this case is   Start Trial .

Details for VISTA HEALTHPLAN, INC. v. CEPHALON, INC. (E.D. Pa. 2006)

Date Filed Document No. Description Snippet Link To Document
2010-03-29 112 issued the RE‘516 patent on January 15, 2002, as a reissue patent for the 5 ,618,845 patent (hereinafter “…Cephalon’s RE‘516 patent The Generic Defendants each asserted patent invalidity, patent unenforceability…of a patent, one (1) court has noted that: Engrafted into patent law is the notion that a patent grant…profiting by the patented invention.” 'fhus, the Patent Act essentially provides the patent owner “With…RE‘S 16 patent because Cephalon knew prior to the underlying patent litigation that the patent was invalid External link to document
2014-06-23 366 . 5,618,845. (Id.) Cephalon later applied for a reissue of this patent, which resulted in the issuance…‘845 patent.) On April 8, 1997, the Patent and Trademark Office issued the patent as U.S. Patent No. …issuance of U.S. Patent RE37,516 (the ‘516 patent). (Ford Decl. Ex. E, ‘516 patent.) … Cephalon submitted the ‘845 patent (later substituted by the ‘516 patent) as covering Provigil. (DPCP… required patent information has not been filed with the FDA; (II) that the relevant patent is expired External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Merck
Express Scripts
AstraZeneca
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.